AstraZeneca

AZ
Biotech

AstraZeneca posts phase 3 bone disease data on Strensiq heir

AstraZeneca shared the data behind previously disclosed phase 3 wins, fleshing out the case for an asset tipped to generate blockbuster sales.
Nick Paul Taylor Jun 29, 2026 4:51am
AZ

ADA: AZ’s oral GLP-1 shows ‘competitive efficacy’ in phase 2

Jun 9, 2026 9:48am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

AstraZeneca adds FDA cell and gene veteran—Chutes & Ladders

Jun 5, 2026 8:30am
Berlin Germany Brandenburg Gate
Favicon Fierce Pharma

Lilly, Boehringer slash investment plans in Germany

Jun 3, 2026 3:10pm
ASCO

ASCO: BMS' bispecific ADC puts TROP2 drugs on notice

Jun 2, 2026 8:00am
success failure signposts

AstraZeneca, after phase 3 miss, posts data behind approval bid

May 29, 2026 10:15am